| 应用对比剂动态增强和扩散加权MRI进行乳腺癌新辅助化疗疗效的评价和预测 |
| |
| 引用本文： | A.Fangberget,L.B.Nilsen,K.H.Hole,M.M.Holmen,O.Engebraaten,B.Naume,胡秀华. 应用对比剂动态增强和扩散加权MRI进行乳腺癌新辅助化疗疗效的评价和预测[J]. 国际医学放射学杂志, 2011, 0(4): 402-403 |
| |
| 作者姓名： | A.Fangberget L.B.Nilsen K.H.Hole M.M.Holmen O.Engebraaten B.Naume 胡秀华 |
| |
| 作者单位： | Department of Radiology and Nuclear Medicine,Norwe-gian Radium Hospital,Oslo University Hospital |
| |
| 摘 要： | 目的探讨在接受新辅助化疗(neoadjuvant chemotherapy,NAC)后获得病理上完全缓解(pathological complete response,pCR)和不能缓解的病人之间,化疗之前MRI参数和肿瘤特征的预测价值,并比较在治疗过程中肿瘤大小和表观扩散系数的改变。方法
|
| 关 键 词： | 预测 乳腺癌 对比剂动态增强MRI ADC 新辅助化疗 |
Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging |
| |
| Affiliation: | A.Fangberget,L.B.Nilsen,K.H.Hole,M.M.Holmen,O.Engebraaten,B.Naume,et al.Department of Radiology and Nuclear Medicine,Norwe-gian Radium Hospital,Oslo University Hospital,Montebello,0310,Oslo,Norway |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 CNKI 等数据库收录！ |
|
